Drug Companies Keep Consumers in the Dark
Unpublished Test Results Show Limited Benefit of Anti-depressants
For the second time in a week, the New York Times has reported that major pharmaceutical companies kept consumers in the dark about the effectiveness of anti-depressants taken by millions of patients.
The makers of Prozac, Paxil and other well-known medications never published the full results of the drug trials. Partial test results that were published showed that 60% of those taking the drugs found relief from depression when compared with a placebo. When all the results are taken into account, though, the anti-depressants only outperformed the placebos by a modest margin.
The Times ran an earlier story about how the manufacturers of Zetia delayed publication of test results that cast doubt on the effectiveness of that widely prescribed anti-cholesterol drug.
"These large drug companies are deliberately withholding information from consumers, physicians and even the federal drug administration," said attorney Roger Gordon. "Personal injury attorneys are the first line of defense for patients who have been harmed. These large companies only understand the bottom line, and they only change their behavior when lawsuits cut into their profits."
Our firm has extensive experience delivering justice to those injured by medications, toxic substances or defective products. If you suspect that you or a loved one has been harmed, please contact us to learn more about your legal options.
Join us on Facebook